DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells

Published:2014-10-17 Issue:1 Volume:7 Page:
ISSN:1756-8722
Container-title:Journal of Hematology & Oncology
language:en
Short-container-title:J Hematol Oncol

Author:

Chu Qian,Han Na,Yuan Xun,Nie Xin,Wu Hua,Chen Yu,Guo Mingzhou,Yu Shiying,Wu Kongming

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Biology,Hematology

Link

http://link.springer.com/content/pdf/10.1186/s13045-014-0073-5.pdf

Reference53 articles.

1. De P, Otterstatter MC, Semenciw R, Ellison LF, Marrett LD: Dryer D Trends in incidence, mortality, and survival for kidney cancer in Canada, 1986–2007.Cancer Causes Control 2014 [Epub ahead of print].,

2. Santoni M, De Tursi M, Felici A, Lo Re G, Ricotta R, Ruggeri EM, Sabbatini R, Santini D, Vaccaro V, Milella M: Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives. Expert Rev Anticancer Ther. 2013, 13 (6): 697-709. 10.1586/era.13.52.

3. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ: Global ARCC Trial. temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med. 2007, 356 (22): 2271-2281. 10.1056/NEJMoa066838.

4. Motzer RJ, Molina AM: Targeting renal cell carcinoma. J Clin Oncol. 2009, 27 (20): 3274-3276. 10.1200/JCO.2009.21.8461.

5. Iacovelli R, Alesini D, Palazzo A, Trenta P, Santoni M, De Marchis L, Cascinu S, Naso G, Cortesi E: Targeted therapies and complete responses in first line treatment of metastatic renal cell carcinoma. a meta-analysis of published trials. Cancer Treat Rev. 2014, 40 (2): 271-275. 10.1016/j.ctrv.2013.09.003.

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Runt-related transcription factor 1 and Notch1 expression in non-small-cell lung cancer: involvement in epithelial-mesenchymal transition and epidermal growth factor receptor-tyrosine kinase inhibitor therapy resistance;The Egyptian Journal of Chest Diseases and Tuberculosis;2024-07

2. Dach1 is essential for maintaining normal mature podocytes;PLOS ONE;2024-05-28

3. Lung-derived soluble factors support stemness/plasticity and metastatic behaviour of breast cancer cells via the FGF2-DACH1 axis;Clinical & Experimental Metastasis;2024-04-06

4. Meta‐analysis of microarray data to determine gene indicators involved in cisplatin resistance in non‐small cell lung cancer;Cancer Reports;2024-02

5. REEP4 as Potential Biomarker Associated with Predictive Prognosis and Immune Response in Kidney Clear Cell Carcinoma;Journal of Cancer;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3